Through the 90-day period concluding January 09, 2026, Atea Pharmaceuticals's top three insider stakeholders include President And Ceo And And Chairman Jean-Pierre Sommadossi (6.17Mn shares), Officer Andrea Corcoran (717.31K shares), Director Franklin M Berger (506.50K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jean-Pierre Sommadossi | President And Ceo And And Chairman | 6,166,965 | 04 Feb, 2025 |
| Andrea Corcoran | Nan | 717,307 | 04 Feb, 2025 |
| Franklin M Berger | 506,497 | 24 Jun, 2025 | |
| Bruno Lucidi | 112,750 | 24 Jun, 2025 | |
| Bruce Polsky | 95,206 | 24 Jun, 2025 | |
| Polly A. Murphy | 86,045 | 24 Jun, 2025 | |
| Janet Mj Hammond | Chief Development Officer | 81,388 | 04 Feb, 2025 |
| Barbara Gayle Duncan | 62,750 | 24 Jun, 2025 | |
| Jerome M. Adams | 62,750 | 24 Jun, 2025 | |
| Maria Arantxa Horga | Chief Medical Officer | 60,876 | 04 Feb, 2025 |
| John Vavricka | Chief Commercial Officer | 52,081 | 04 Feb, 2025 |
| Wayne Foster | Evp And Chief Accounting Officer | 50,128 | 04 Feb, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Jun, 2025 | Franklin M Berger | Common Stock | A | 29,600 | $0.00 | 506,497 | D | M |
| 20 Jun, 2025 | Barbara Gayle Duncan | Common Stock | A | 29,600 | $0.00 | 62,750 | D | M |
| 20 Jun, 2025 | Bruce Polsky | Common Stock | A | 29,600 | $0.00 | 95,206 | D | M |
| 20 Jun, 2025 | Polly A. Murphy | Common Stock | A | 29,600 | $0.00 | 86,045 | D | M |
| 20 Jun, 2025 | Bruno Lucidi | Common Stock | A | 29,600 | $0.00 | 112,750 | D | M |
| 20 Jun, 2025 | Jerome M. Adams | Common Stock | A | 29,600 | $0.00 | 62,750 | D | M |
| 31 Jan, 2025 | Jean-Pierre Sommadossi | Common Stock | A | 173,467 | - | 290,024 | D | M |
| 31 Jan, 2025 | Jean-Pierre Sommadossi | Common Stock | D | 88,601 | $3.06 | 300,940 | D | F |
| 31 Jan, 2025 | Jean-Pierre Sommadossi | Common Stock | A | 99,517 | - | 389,541 | D | A |
| 31 Jan, 2025 | Andrea Corcoran | Common Stock | A | 44,367 | - | 722,909 | D | M |
| 31 Jan, 2025 | Andrea Corcoran | Common Stock | A | 10,500 | - | 733,409 | D | A |
| 31 Jan, 2025 | Andrea Corcoran | Common Stock | D | 16,102 | $3.06 | 717,307 | D | F |
| 31 Jan, 2025 | Wayne Foster | Common Stock | D | 12,062 | $3.06 | 50,128 | D | F |
| 31 Jan, 2025 | Wayne Foster | Common Stock | A | 33,333 | - | 54,190 | D | M |
| 31 Jan, 2025 | Wayne Foster | Common Stock | A | 8,000 | - | 62,190 | D | A |
| 31 Jan, 2025 | Maria Arantxa Horga | Common Stock | A | 9,750 | - | 76,947 | D | A |
| 31 Jan, 2025 | Maria Arantxa Horga | Common Stock | A | 41,533 | - | 67,197 | D | M |
| 31 Jan, 2025 | Maria Arantxa Horga | Common Stock | D | 16,071 | $3.06 | 60,876 | D | F |
| 31 Jan, 2025 | John Vavricka | Common Stock | A | 33,333 | - | 54,848 | D | M |
| 31 Jan, 2025 | John Vavricka | Common Stock | D | 11,517 | $3.06 | 52,081 | D | F |